je.st
news
Tag: diseases
Dangerous Honeybee Diseases Jump to Wild Pollinators
2015-05-07 19:04:00| Climate Ark Climate Change & Global Warming Newsfeed
Nature World: Ever since it was first noticed in 2006 that America's honeybees were dying en masse, the spotlight has been on these essential pollinators. It was quickly revealed that not only US honeybees, but entire global populations were in trouble, with troubling declines in Europe and even Australia. Now a new investigation has revealed that a suite of diseases that once exclusively affected domestic honeybees has moved on to infect wild bees, such as the common bumblebee, as well. That's at least according...
Tags: jump
wild
dangerous
diseases
Australia: Climate change: Diseases, heatwaves, lost jobs to impact human health, experts warn
2015-04-30 03:28:00| Climate Ark Climate Change & Global Warming Newsfeed
Australian Broadcasting Corporation: Australia's top doctors and scientists are urging the Government to show leadership on climate change after a new report warned human health would feel the most immediate impacts of global warming. The report from the Australian Academy of Science was endorsed by the Australian Medical Association and highlighted unemployment, population displacement and social inequality as potential impacts to society. "Whether it be more heatwaves, tropical diseases moving to new areas or lost jobs in farming,...
Merck Announces Publication of Pivotal Data from Phase 3 Clinical Studies of ZERBAXA (Ceftolozane/Tazobactam) in The Lancet and Clinical Infectious Diseases
2015-04-28 00:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that The Lancet and Clinical Infectious Diseases have published online the results from the pivotal Phase 3 clinical studies of ZERBAXA (ceftolozane/tazobactam) for Injection (1 g/0.5 g) in complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI), respectively. The results will also appear in forthcoming print issues of the journals. Language: English Contact: MerckMedia Contacts:Pam Eisele, 267-305-3558Robert Consalvo, 908-295-0928orInvestor Contacts:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: the
data
publication
studies
Merck Reaffirms Continued Commitment to Developing Innovative Medicines for the Treatment of Infectious Diseases at 25th Annual ECCMID Congress
2015-04-21 14:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today reaffirmed its longstanding commitment to discovering and developing novel medicines in the global fight against infectious diseases, including infections caused by resistant bacteria and other pathogens. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orRobert Consalvo, 908-295-0928orInvestors:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: treatment
continued
annual
developing
Drugs against Autoimmune Diseases: Model Line from Bosch Comprises All Process Steps
2015-04-16 12:31:11| Industrial Newsroom - All News for Today
From formulation to secondary packaging New, small-volume fermenter for product development Flexible filling and closing processes combined with isolator and new wireless glove testing system Comprehensive portfolio for handling, sterilization, inspection and secondary packaging Frankfurt/Main, Germany At...
Tags: line
process
model
steps
Sites : [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] next »